DuPont Wins R&D 100 Award for Innovation in Healthcare
DuPont (NYSE: DD) announced that its DuPont™ Liveo™ Pharma TPE Ultra-Low Temp Tubing has won a 2026 R&D 100 Award in the Mechanical/Materials category, recognizing it among the 100 most innovative technologies of the previous year.
Rhea-AI Summary
DuPont (NYSE: DD) announced that its DuPont™ Liveo™ Pharma TPE Ultra-Low Temp Tubing has won a 2026 R&D 100 Award in the Mechanical/Materials category, recognizing it among the 100 most innovative technologies of the previous year.
The sterilizable, weldable and sealable thermoplastic elastomer tubing is designed for biopharmaceutical processing, manufactured in an ISO Class 7 cleanroom, and maintains toughness and flexibility down to -86°C. According to DuPont, it resists bending, crushing, impact, chemicals and burst pressure, and is supported by a comprehensive regulatory and validation data package for high-purity fluid transfer and single-use processing applications. DuPont™ FilmTec™ Fortilife™ XC220 reverse osmosis membrane technology was also named an R&D 100 Finalist for addressing challenging industrial water reuse, brine management and resource recovery applications.
Positive
- None.
Negative
- None.
Details
News Market Reaction – DD
In the Aug 6 session, DD declined 2.25%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
- Award year
- 2026
- R&D 100 Award
- Recognized technologies
- 100 technologies
- R&D 100 Awards scope
- Low-temperature performance
- -86°C
- Liveo Pharma TPE Ultra-Low Temp Tubing
- Cleanroom classification
- ISO Class 7
- Tubing manufacturing cleanroom
- Awards history
- 64th year
- R&D 100 Awards
- Entries represented
- 8 countries and regions
- 2026 R&D 100 Awards
- Judges
- More than 50 industry professionals
- 2026 R&D 100 Awards judging
Historical Context
-
Valtris announced four senior executive appointments focused on operations, customer service, and growth.
-
DuPont launched a direct lithium extraction portfolio spanning more than 20 products.
-
DuPont scheduled its second quarter 2026 results release and earnings conference call.
-
DuPont launched a web-based water treatment design tool integrating multiple technologies.
-
McNICHOLS appointed Mateus Panosso as president following its partnership with One Equity Partners.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
thermoplastic elastomer technical
iso class 7 cleanroom technical
reverse osmosis technical
brine management technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
Award-winning DuPont™ Liveo™ Pharma TPE Ultra-Low Temp Tubing advances biopharma processing applications
"We're honored to have one of our DuPont innovations recognized among the year's most significant technology achievements," said Marty DeGroot, DuPont Chief Technology Officer. "Winning an R&D 100 Award reflects the dedication and ingenuity of our teams, who continue to develop advanced technologies and solutions that deliver performance, value and meaningful impact for our customers."
DuPont™ Liveo™ Pharma TPE Ultra-Low Temp Tubing is designed for biopharmaceutical processing applications that require exposure to extremely low temperatures, Liveo™ Pharma TPE Ultra-Low Temp Tubing is a sterilizable, weldable, and sealable thermoplastic elastomer tubing manufactured in an ISO Class 7 cleanroom. The tubing maintains toughness and flexibility down to -86°C and offers strong resistance to bending, crushing, impact, chemicals, and burst pressure. Supported by a comprehensive regulatory and validation data package, it provides biopharma manufacturers with a high-purity solution for fluid transfer and single-use processing applications while expanding DuPont's portfolio of Liveo™ biopharma processing technologies.
DuPont™ FilmTec™ Fortilife™ XC220 Element was also named an R&D 100 Finalist. The reverse osmosis membrane technology helps customers address some of the most challenging industrial water reuse, brine management, and resource recovery applications.
The R&D 100 Awards, now in its 64th year, are widely recognized as the "Oscars of Innovation," as they identify and celebrate the top technology products and services of the year. This year, the R&D 100 Awards received entries from 8 different countries and regions and nominations were judged by more than 50 well-respected industry professionals from across the world.
About DuPont
DuPont (NYSE: DD) is a global innovation leader, providing advanced solutions that help transform industries and improve everyday life across our key markets of healthcare, water, construction, and industrial. More information about the company, its businesses and solutions can be found at www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.
DuPont™, the DuPont Oval Logo, and all trademarks and service marks denoted with ™, ℠ or ® are owned by affiliates of DuPont de Nemours, Inc. unless otherwise noted.
View original content to download multimedia:https://www.prnewswire.com/news-releases/dupont-wins-rd-100-award-for-innovation-in-healthcare-302845251.html
SOURCE DuPont
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.